Partner
MPM BioImpact
Brookline, MA, United States
Dr. Florencia Pereyra Segal is a Partner at MPM BioImpact.
Florencia is an Infectious Diseases physician-scientist, drug development leader, and biotech investor. In her current role, she is responsible for leading biotech investments and new company creation activities. Florencia serves as a member of the Board of Directors of Antiva Biosciences. Previously she was the Global Head of Translational Medicine for Global Health at Novartis, her group was responsible for the translational and early clinical development of antivirals, antibiotics, and antiparasitic therapies. Before her industry career, Florencia was a Principal Investigator leading translation research in HIV controllers at the Ragon Institute of MGH, MIT, and Harvard.
Florencia completed her specialty in Infectious Diseases and post-doctoral training at Brigham and Women’s and Massachusetts General Hospital, where she has practiced infectious diseases for over 20 years.
Disclosure(s): No financial relationships to disclose
Wednesday, October 16, 2024
11:10 AM – 12:15 PM US PT